Bristol-Myers Copay Subsidies Not Bribes, Judge Finds
A federal judge said Monday that Bristol-Myers Squibb Co.'s practice of subsidizing patients' drug copays didn't constitute illegal bribery, dismissing a putative class action brought by insurers that complain the payments push...To view the full article, register now.
Already a subscriber? Click here to view full article